MedTrace Logo

MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure

NCT00468299 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2011-07-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare two combinations of drugs (mifepristone and misoprostol versus placebo and misoprostol) used for medical treatment for early pregnancy failure. We will compare the two combinations of medications to see which combination makes miscarriage happen faster. We hypothesize that there will be no difference in time to complete miscarriage between the two groups.

Conditions

  • Early Pregnancy Failure
  • Miscarriage
  • Fetal Demise
  • Anembryonic Pregnancy

Interventions

DRUG

Misoprostol and placebo

Women in this group receive 800 mcg misoprostol plus a placebo

DRUG

Mifepristone and misoprostol

This group receives mifepristone 200 mg orally; followed by 800 mcg misoprostol bucally

Sponsors & Collaborators

  • Boston University

    lead OTHER

Principal Investigators

  • Sarah J Betstadt, MD · Boston University

  • Olivera Vragovic, MBA · Boston University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00468299 on ClinicalTrials.gov